Bionano Genomics, Inc.
BNGO
$3.60
-$0.0513-1.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 63.10% | 51.82% | 40.26% | -39.30% | -62.26% |
| Total Depreciation and Amortization | -0.55% | 2.26% | 17.90% | 13.37% | 26.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.20% | -77.38% | -67.36% | 278.83% | 294.85% |
| Change in Net Operating Assets | 118.30% | 129.80% | 71.81% | 80.84% | 70.33% |
| Cash from Operations | 63.97% | 44.94% | 29.04% | 20.98% | 3.08% |
| Capital Expenditure | 94.33% | 93.91% | 64.74% | 64.77% | 47.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | 100.31% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -78.28% | 187.12% | -86.92% | -44.55% | -44.22% |
| Cash from Investing | -77.93% | 205.65% | -83.03% | -17.35% | -17.99% |
| Total Debt Issued | -77.50% | -77.50% | -- | -- | -- |
| Total Debt Repaid | 35.69% | -630.16% | -165,938.64% | -170,763.41% | -120,200.00% |
| Issuance of Common Stock | -27.04% | -23.14% | 5.02% | -9.05% | 49.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 19.12% | 32.68% | -1,886.30% | -1,476.61% | -1,462.73% |
| Cash from Financing | -75.66% | -112.02% | 11.94% | 3.49% | 104.25% |
| Foreign Exchange rate Adjustments | 233.33% | -110.77% | -56.31% | 200.00% | 250.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -207.54% | -168.25% | -478.92% | 155.25% | 159.63% |